Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates

Journal of Clinical Microbiology

Volumn 42, Issue 8, 2004, Pages 3570-3574

  Daly, Melissa M ^a   Doktor, Stella ^a   Flamm, Robert ^a,b   Shortridge, Dee ^a  

^a ABBOTT LABORATORIES   (United States)

^b Focus Technologies Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CETHROMYCIN; DALFOPRISTIN; ERYTHROMYCIN; QUINUPRISTIN; TELITHROMYCIN; UNCLASSIFIED DRUG;

AFRICA; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM TRANSFORMATION; CANADA; CONTROLLED STUDY; EUROPE; GENE AMPLIFICATION; MEFA GENE; MEFE GENE; MOLECULAR CLONING; MSRD GENE; NONHUMAN; NORTH AMERICA; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SEROPREVALENCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; GEOGRAPHY; HUMANS; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

ANIMALIA; BACTERIA (MICROORGANISMS); POSIBACTERIA; PROKARYOTA; STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 3843101620     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.8.3570-3574.2004     Document Type: Article

References (21)

1. Alloing, G., M. C. Trombe, and J. P. Claverys. 1990. The ami locus of the gram-positive bacterium Streptococcus pneumoniae is similar to binding protein-dependent transport operons of gram-negative bacteria. Mol. Microbiol. 4:633-644.
2. Amezaga, M. R., P. E. Carter, P. Cash, and H. McKenzie. 2002. Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J. Clin. Microbiol. 40:3313-3318.
3. Clancy, J., J. Petitpas, F. Dib-Hajj, W. Yuan, M. Cronan, A. V. Kamath, J. Bergeron, and J. A. Retsema. 1996. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:867-879.
4. Claverys, J. P., A. Dintilhac, E. V. Pestova, B. Martin, and D. A. Morrison. 1995. Construction and evaluation of new drug-resistance cassettes for gene disruption mutagenesis in Streptococcus pneumoniae, using an ami test platform. Gene 164:123-128.
5. Colman, G., E. M. Cooke, B. D. Cookson, P. G. Cooper, A. Efstratiou, and R. C. George. 1998. Pneumococci causing invasive disease in Britain 1982-1990. J. Med. Microbiol, 47:17-27.
6. Del Grosso, M., F. Iannelli, C. Messina, M. Santagati, N. Petrosillo, S. Stefani, G. Pozzi, and A. Pantosti. 2002. Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40:774-778.
7. Doktor, S. Z., V. D. Shortridge, J. M. Beyer, and R. K. Flamm. 2004. Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations. Diagn. Microbiol. Infect. Dis. 49:47-52.
8. Gusaffero, C. 1993. Chemiluminescent ribotyping, p. 584-594. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
9. Hoban, D. J., A. K. Wierzbowski, K. Nichol, and G. G. Zhanel. 2001. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. Antimicrob. Agents Chemother. 45:2147-2150.
10. Jorgensen, J. H., S. A. Crawford, M. L. McElmeel, and C. G. Whitney. 2004. Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 48:605-607.
11. Leclercq, R., and P. Courvalin. 1991. Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob. Agents Chemother. 35:1273-1276.
12. Matsuoka, M., L. Janosi, K. Endou, and Y. Nakajima. 1999. Cloning and sequences of inducible and constitutive macrolide resistance genes in Staphylococcus aureus that correspond to an ABC transporter. FEMS Microbiol. Lett. 181:91-100.
13. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing; 12th informational supplement (aerobic dilution). Supplemental tables M100-S12. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Pestova, E. V., and D. A. Morrison. 1998. Isolation and characterization of three Streptococcus pneumoniae transformation-specific loci by use of a lacZ reporter insertion vector. J. Bacteriol. 180:2701-2710.
15. Podbielski, A., B. Spellerberg, M. Woischnik, B. Pohl, and R. Lutticken. 1996. Novel series of plasmid vectors for gene inactivation and expression analysis in group A streptococci (GAS). Gene 177:137-147.
16. Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
17. Ross, J. I., E. A. Eady, J. H. Cove, W. J. Cunliffe, S. Baumberg, and J. C. Wootton. 1990. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4:1207-1214.
18. Shortridge, V. D., R. K. Flamm, N. Ramer, J. Beyer, and S. K. Tanaka. 1996. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 26:73-78.
19. Tait-Kamradt, A., J. Clancy, M. Cronan, F. Dib-Hajj, L. Wondrack, W. Yuan, and J. Sutcliffe. 1997. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:2251-2255.
20. Yu, L., A. H. Gunasekera, J. Mack, E. T. Olejniczak, L. E. Chovan, X. Ruan, D. L. Towne, C. G. Lerner, and S. W. Fesik. 2001. Solution structure and function of a conserved protein SP14.3 encoded by an essential Streptococcus pneumoniae gene. J. Mol. Biol. 311:593-604.
21. Zhanel, G. G., T. Hisanaga, K. Nichol, A. Wierzbowski, and D. J. Hoban. 2003. Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae. Expert Opin. Emerg. Drugs 8:297-321.